Heterotypic interaction promotes asymmetric division of human hematopoietic progenitors.
Asymmetric division
Hematopoiesis
Heterotypic interaction
Microfabrication
Niches
Stem cells
Journal
Development (Cambridge, England)
ISSN: 1477-9129
Titre abrégé: Development
Pays: England
ID NLM: 8701744
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
received:
22
05
2024
accepted:
17
07
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
aheadofprint
Résumé
Hematopoietic Stem and Progenitor Cells (HSPCs) give rise to all cell types of the hematopoietic system through various processes including asymmetric divisions. However, the contribution of stromal cells of the hematopoietic niches in the control of HSPC asymmetric divisions remains unknown. Using polyacrylamide microwells as minimalist niches, we show that specific heterotypic interaction with osteoblast and endothelial cell promote asymmetric division of human HSPC. Upon interaction, HSPCs polarize in interphase with the centrosome, the Golgi apparatus, and lysosomes positioned close to the site of contact. Subsequently, during mitosis, HSPCs orient their spindle perpendicular to the plane of contact. This division mode gives rise to siblings with unequal amounts of lysosomes and of CD34 differentiation marker. Such asymmetric inheritance generates heterogeneity in the progeny, which is likely to contribute to the plasticity of the early steps of hematopoiesis.
Identifiants
pubmed: 39136544
pii: 361645
doi: 10.1242/dev.203088
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Research Council
ID : 771599
Pays : International
Organisme : European Research Council
ID : 741773
Pays : International
Organisme : Bettencourt-Schueller foundation
Organisme : Emergence program of the Ville de Paris
Organisme : Schlumberger foundation for education and research
Organisme : Fondation pour la Recherche Medicale
Informations de copyright
© 2024. Published by The Company of Biologists Ltd.